{"analyses":[{"groupDescription":"At 2 hours after initial mouthwash","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.1392","statisticalMethod":"Chi-squared"},{"groupDescription":"At 4 hours after initial mouthwash","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.6989","statisticalMethod":"Chi-squared"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8"},{"groupId":"OG001","value":"2.9"}]}],"title":"At 2 hours after the initial mouthwash"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.9"},{"groupId":"OG001","value":"14.5"}]}],"title":"At 4 hours after the initial mouthwash"}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"71"}],"units":"Participants"}],"description":"The incidence of utilizing additional analgesics between 2 and 4 hours after the initial mouthwash will be compared between the arms by the Chi-square test .","groups":[{"description":"Patients receive (10 mg/mL x 2.5 mL) 25 mg doxepin hydrochloride (diluted to 5 mL with 2.5 mL of sterile water for irrigation, or sterile water for injection, or distilled water) oral rinse (swish, gargle, and spit) over 1 minute on day 1. Patients may crossover to arm II on day 2.","id":"OG000","title":"Arm I (Doxepin-Placebo)"},{"description":"Patients receive 2.5 mL placebo (diluted to 5 mL with 2.5 mL of sterile water for irrigation, or sterile water for injection, or distilled water) oral rinse (swish, gargle, and spit) over 1 minute on day 1. Patients may crossover to arm I on day 2.","id":"OG001","title":"Arm II (Placebo-Doxepin)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 9 days","title":"Incidence of Using Alternative Analgesics Between 2 and 4 Hours After the Initial Mouthwash","type":"SECONDARY","unitOfMeasure":"percentage of patients"}